About RApport
RApport is a company based in Camberley (United Kingdom) founded in 2003 was acquired by Eliquent in January 2024. The company has 6 employees as of March 31, 2021. RApport offers products and services including Strategic Services, Development Support, Regulatory Affairs Support, Operational Improvements, and Medical Writing. RApport operates in a competitive market with competitors including ProPharma Group, PharmaLex, Validant, Technical Safety Services and Celegence, among others.
- Headquarter Camberley, United Kingdom
- Employees 6 as on 31 Mar, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Rapport Global Strategic Services Ltd
- Date of Incorporation 27 Mar, 2018
- Jurisdiction SURREY, UNITED KINGDOM
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RApport
RApport offers a comprehensive portfolio of products and services, including Strategic Services, Development Support, Regulatory Affairs Support, Operational Improvements, and Medical Writing.
Offers regulatory strategy for pharmaceutical development
Assists in implementing regulatory plans for products
Manages applications through regulatory processes
Enhances regulatory department capabilities
Provides writing for medical and regulatory documents
People of RApport
Unlock access to complete
Funding Insights of RApport
Detailed funding history for RApport
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in RApport
RApport has secured backing from 1 investor. Prominent investors backing the company include Eliquent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Offers regulatory affairs and compliance solutions for life sciences companies globally.
|
Locked | Locked | Locked |
Investor details for RApport
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RApport
Investment portfolio details for RApport
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RApport
Detailed financials for RApport
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rapport Comparisons
Peer comparison for RApport
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RApport
RApport operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProPharma Group, PharmaLex, Validant, Technical Safety Services and Celegence, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device
|
|
| Locked | Locked | Locked |
CRO specializing in regulatory affairs and pharmacovigilance
|
|
| Locked | Locked | Locked |
Regulatory, compliance, and quality consulting for GxP lifecycles is provided.
|
|
| Locked | Locked | Locked |
Healthcare instrumentation, medical gas systems, and related devices are manufactured.
|
|
| Locked | Locked | Locked |
Regulatory consulting and solutions for pharmaceuticals and medical devices compliance.
|
|
| Locked | Locked | Locked |
Provides radiopharmaceutical equipment, synthesis solutions, and custom services for labs.
|
Detailed competitors of RApport
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rapport
Complete news archive for RApport
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RApport
RApport was founded in 2003.
RApport is headquartered in Camberley, United Kingdom. It is registered at Camberley, Surrey, United Kingdom.
Lorna Griffin is the current CEO of RApport.
As of Mar 31, 2021, the latest employee count at RApport is 6.
RApport Global was founded in 2003 and is based in Camberley, United Kingdom. An international regulatory consultancy is operated, with services encompassing regulatory affairs support, medical writing, and strategic advisory for the pharmaceutical sector. Operations extend globally, and the firm is headed by CEO Lorna Griffin.
RApport's top competitors include ProPharma Group, PharmaLex and Pharma-Bio Serv.
RApport offers Strategic Services, Development Support, Regulatory Affairs Support, Operational Improvements, and Medical Writing.
RApport has 1 investor. Key investors include Eliquent.